In vitro activity of tubercidin against Mycobacterium tuberculosis and nontuberculosis Mycobacteria

In vitro activity of fidaxomicin against nontuberculosis mycobacteria

(2022) Qing Sun et al.   JOURNAL OF MEDICAL MICROBIOLOGY

In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria

(2022) Tingting Zhang et al.   Microbiology Spectrum

Fidaxomicin has high in vitro activity against Mycobacterium tuberculosis

(2021) Qing Sun et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Nucleoside Analogues as Antibacterial Agents

(2019) Jessica M. Thomson et al.   Frontiers in Microbiology

Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness

(2019) Fabian Hulpia et al.   Nature Communications

Characterization of a Novel Endoplasmic Reticulum Protein Involved in Tubercidin Resistance in Leishmania major

(2016) Juliana Ide Aoki et al.   PLoS Neglected Tropical Diseases

Novel diagnostics and therapeutics for drug-resistant tuberculosis

(2014) M. Toosky et al.   BRITISH MEDICAL BULLETIN

Identification of 5-Iodotubercidin as a Genotoxic Drug with Anti-Cancer Potential

(2013) Xin Zhang et al.   PLoS One